| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.5 | 0.003 |